The Future of "Omics" in Hypertension.

about

Genetic Programming of Hypertension.Utilizing proteomics to understand and define hypertension: where are we and where do we go?

P2860

Q49520111-48946222-AC56-4ED7-A52D-EF044BEDEB94 Q58227790-A8E1F9F8-1D35-42AC-A40A-997C206F0FF2

P2860

The Future of "Omics" in Hypertension.

Item

http://www.wikidata.org/entity/Q33638423

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The Future of "Omics" in Hypertension.

@ast

The Future of "Omics" in Hypertension.

@en

type

Item

label

The Future of "Omics" in Hypertension.

@ast

The Future of "Omics" in Hypertension.

@en

prefLabel

The Future of "Omics" in Hypertension.

@ast

The Future of "Omics" in Hypertension.

@en

P1476

The Future of "Omics" in Hypertension.

@en

P2093

Christian Delles

http://www.w3.org/2001/XMLSchema#string

Gemma Currie

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The Isolation of Biochemically Deficient Mutants of Bacteria by Means of Penicillin

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Rare independent mutations in renal salt handling genes contribute to blood pressure variation

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

Current Applications of Genetic Risk Scores to Cardiovascular Outcomes and Subclinical Phenotypes

Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association

Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.

A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.

Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association

High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis

P304

601-610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.CJCA.2016.11.023

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christian Delles

P5008

ScienceSource

P577

2016-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28161100

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

5417769

http://www.w3.org/2001/XMLSchema#string

The Future of "Omics" in Hypertension.

about

P2860

P2860

The Future of "Omics" in Hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932